flurbiprofen has been researched along with Adenocarcinoma in 9 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Flurbiprofen, indomethacin and other NSAIDs stimulated 15-PGDH activity in colon cancer HT29 cells as well as in lung cancer A549 cells and glioblastoma T98G cells." | 4.87 | Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). ( Chi, X; Tai, HH; Tong, M, 2011) |
| "Adenocarcinoma in Barrett's esophagus has been increasing in incidence at a rapid rate for more than two decades." | 1.31 | Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. ( Beer, DG; Cryer, B; Shewmake, K; Souza, RF; Spechler, SJ, 2000) |
| " Flurbiprofen did not seem to alter the bioavailability of the chemotherapeutic agents." | 1.26 | Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. ( Bennett, A; Berstock, DA; Carroll, MA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tai, HH | 1 |
| Chi, X | 1 |
| Tong, M | 1 |
| Karmali, RA | 3 |
| Bennett, A | 2 |
| Berstock, DA | 2 |
| Carroll, MA | 1 |
| Tutton, PJ | 1 |
| Barkla, DH | 1 |
| Houghton, J | 1 |
| Wechter, WJ | 1 |
| Leipold, DD | 1 |
| Murray, ED | 1 |
| Quiggle, D | 1 |
| McCracken, JD | 1 |
| Barrios, RS | 1 |
| Greenberg, NM | 1 |
| Souza, RF | 1 |
| Shewmake, K | 1 |
| Beer, DG | 1 |
| Cryer, B | 1 |
| Spechler, SJ | 1 |
| Lehnert, T | 1 |
| Deschner, EE | 1 |
| DeCosse, JJ | 1 |
| Marsh, J | 1 |
1 review available for flurbiprofen and Adenocarcinoma
| Article | Year |
|---|---|
Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, | 2011 |
8 other studies available for flurbiprofen and Adenocarcinoma
| Article | Year |
|---|---|
Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione.
Topics: Adenocarcinoma; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Female; Flurbiprofen; Glutathione; | 1984 |
Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
Topics: Adenocarcinoma; Animals; Biological Availability; Body Weight; Drug Therapy, Combination; Female; Fl | 1982 |
Influence of prostaglandin analogues on epithelial cell proliferation and xenograft growth.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Epithelium; Female; Flurbiprofen; Humans; Intestines; Ma | 1980 |
Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
Topics: Adenocarcinoma; Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Mammary Neoplasms, Expe | 1980 |
E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
Topics: Adenocarcinoma; Animals; Body Weight; Dietary Fats; Disease Models, Animal; Disease Progression; Flu | 2000 |
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Barrett Esophagus; Cell Division | 2000 |
Effect of flurbiprofen and 16,16-dimethyl prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats: glandular epithelium of stomach and duodenum.
Topics: 16,16-Dimethylprostaglandin E2; Adenocarcinoma; Animals; Body Weight; Duodenal Neoplasms; Female; Fl | 1990 |
Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2.
Topics: Adenocarcinoma; Animals; Antibodies; Antineoplastic Agents; Cell Line; Cyclooxygenase Inhibitors; Di | 1985 |